Biology subjects

Burgkart, R.

Publications and source records attributed to Burgkart, R..

3 recordsLinked to original sources

bioRxiv2026

SmartSpacer: Design, Implementation, and In-Vitro Validation of a Multimodal Sensorized Knee Spacer for Continuous Infection Monitoring in Two-Stage Revision Arthroplasty

Periprosthetic joint infection (PJI) is the leading cause of failure in two-stage revision total knee arthroplasty (TKA). The timing of reimplantation currently relies on subjective clinical assessment, as no established method enables continuous, objective, local monitoring of infection dynamics during the spacer interval. We present the SmartSpacer, a sensorized antibiotic-loaded PMMA knee spacer integrating a miniaturized PCB within the tibial component (65 x 45 x 12 mm). The system incorporates digital temperature sensors, a CMOS camera module, a spectrometer, an inertial measurement unit, and a Bluetooth Low Energy (BLE) 5.2 transceiver. Firmware was developed on Zephyr RTOS with aggressive power management. Validation experiments covered power consumption profiling, BLE signal transmission through air, phantom liquid, and ex-vivo porcine knee tissue, temperature accuracy against a calibrated PT100 reference, and motion detection in seven healthy volunteers across three activity protocols. Firmware optimization reduced quiescent current from 700-850 {micro}A to 8 {micro}A, projecting a battery life exceeding 600 days at a clinically relevant sampling rate of one image and one spectrum per hour -- more than an order of magnitude beyond the maximum spacer implantation duration. BLE connectivity was maintained reliably up to 6 m through tissue-equivalent phantom liquid and up to 8-9 m in open air. Temperature sensors achieved {+/-}0.16 {degrees}C steady-state accuracy with self-heating artefacts below 0.15 {degrees}C. Motion detection scaled proportionally with activity intensity, though inter-subject variability in crutch-walking indicated that patient-specific calibration will be required. The SmartSpacer introduces an in vivo wearable - a temporary, implantable knee spacer providing continuous, wireless, multiparametric monitoring within the joint space. It has the potential to transform two-stage revision arthroplasty from empirically timed to data-driven, individualized clinical decision-making.

bioengineering↗

bioRxiv2026

Towards In Vivo Wearable Diagnostics in Orthopaedics: Sensorized Bone Cement for Knee Spacer Applications

Periprosthetic joint infection (PJI) is a severe complication of total knee arthroplasty and is a leading cause of revision surgery, and is associated with significant morbidity. Two-stage exchange using antibiotic-loaded polymethylmethacrylate (PMMA) spacers remains the clinical gold standard, yet the decision to reimplant relies largely on indirect markers and clinical judgment, as no method allows continuous in situ assessment of infection resolution. Here, we report a sensorized knee spacer that transforms PMMA bone cement from a passive structural material into an active, wearable diagnostic device. A miniaturized multimodal sensor unit integrating optoelectronic and physicochemical sensing was embedded within the tibial spacer component and wirelessly coupled, enabling energy-efficient, 24/7 in vivo monitoring during the spacer interval for several months. We developed a reproducible encapsulation and integration strategy compatible with clinically realistic spatial, thermal, and mechanical constraints, without altering the established surgical workflow. The functionality of the embedded camera, spectrometer, and temperature sensors following cement integration was verified. Mechanical integrity and signal stability were confirmed under ISO-compliant dynamic biomechanical loading conditions. In vivo validation of the implantable wearable was preclinically demonstrated in a porcine model using human knee spacer dimensions. These findings establish the technical feasibility of sensor-integrated PMMA spacers and introduce bone cement as an enabling platform for smart orthopedic implants. Continuous, local monitoring of the peri-implant environment may open new pathways for evidence-based decision-making in infection management with temporary implantable wearables.

bioengineering↗

bioRxiv2020

Porcine model elucidates function of p53 isoform in carcinogenesis

BackgroundThe pig has long been an important animal species for biomedical research. Recent years has also seen an increasing number of genetically engineered pig models of human diseases including cancer. We previously generated pigs with a modified TP53 allele which carries a Cre-removable transcriptional stop signal in intron 1, and an oncogenic mutation TP53R167H (orthologous to human TP53R175H and mouse Trp53R172H) in exon 5. Pigs with the unrecombined mutant allele (flTP53R167H) develop osteosarcoma (OS) in aged heterozygous and young homozygous animals. In addition, some homozygous animals also developed nephroblastomas and lymphomas. This observation suggested that TP53 gene dysfunction is itself the key initiator of tumorigenesis, but raises the question which aspects of the TP53 regulation leads to the development of such a narrow tumour spectrum, mainly OS. MethodsWe performed a series of molecular and cellular analyses to study the regulation of TP53 and its family members in both healthy tissue and tumours (n= 48) from flTP53R167H pigs. Human OS cell lines were used to prove relevance to human patients. ResultsMolecular analyses of p53 revealed the presence of two internal TP53 promoters (Pint and P2) equivalent to those found in human. Consequently, both pigs and human express TP53 isoforms. Data presented here strongly suggest that P2-driven expression of the mutant R167H-{Delta}152p53 isoform (equivalent to the human R175H-{Delta}160p53 isoform) and its circular counterpart circTP53 determine the tumour spectrum and play a critical role in the malignant transformation of bones, kidney or spleen in flTP53R167H pigs. The detection of {Delta}152p53 isoform mRNA in serum is indicative of tumorigenesis. Furthermore, we showed a tissue-specific p53-dependent deregulation of the p63 and p73 isoforms in these tumours. ConclusionsThis study highlights important species-specific differences in the transcriptional regulation of TP53. For the first time a circTP53 RNA was identified. Results indicate that the {Delta}152p53 isoform, its circular circTP53 and p53 family members, TAp63{delta} and TAp73{delta}, likely play a role in the malignant transformation of bone and other tumours. Considering the similarities of TP53 regulation between pig and human, these observations provide useful pointers for further investigation into isoform function including the novel circTP53 in both the pig model and human patients.

cancer biology↗